140 related articles for article (PubMed ID: 35131382)
1. CYLD deficiency enhances metabolic reprogramming and tumor progression in nasopharyngeal carcinoma via PFKFB3.
Wang L; Lin Y; Zhou X; Chen Y; Li X; Luo W; Zhou Y; Cai L
Cancer Lett; 2022 Apr; 532():215586. PubMed ID: 35131382
[TBL] [Abstract][Full Text] [Related]
2. The E3 ubiquitin ligase MIB2 enhances inflammation by degrading the deubiquitinating enzyme CYLD.
Uematsu A; Kido K; Takahashi H; Takahashi C; Yanagihara Y; Saeki N; Yoshida S; Maekawa M; Honda M; Kai T; Shimizu K; Higashiyama S; Imai Y; Tokunaga F; Sawasaki T
J Biol Chem; 2019 Sep; 294(38):14135-14148. PubMed ID: 31366726
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA LINC00930 promotes PFKFB3-mediated tumor glycolysis and cell proliferation in nasopharyngeal carcinoma.
He B; Pan H; Zheng F; Chen S; Bie Q; Cao J; Zhao R; Liang J; Wei L; Zeng J; Li H; Cui X; Ding Y; Chao W; Xiang T; Cheng Y; Qiu G; Huang S; Tang L; Chang J; Luo D; Yang J; Zhang B
J Exp Clin Cancer Res; 2022 Feb; 41(1):77. PubMed ID: 35209949
[TBL] [Abstract][Full Text] [Related]
4. LPLUNC1 reduces glycolysis in nasopharyngeal carcinoma cells through the PHB1-p53/c-Myc axis.
Oyang L; Ouyang L; Yang L; Lin J; Xia L; Tan S; Wu N; Han Y; Yang Y; Li J; Chen X; Tang Y; Su M; Luo X; Li J; Xiong W; Zeng Z; Liao Q; Zhou Y
Cancer Sci; 2023 Mar; 114(3):870-884. PubMed ID: 36382614
[TBL] [Abstract][Full Text] [Related]
5. Viral oncoprotein LMP1 disrupts p53-induced cell cycle arrest and apoptosis through modulating K63-linked ubiquitination of p53.
Li L; Li W; Xiao L; Xu J; Chen X; Tang M; Dong Z; Tao Q; Cao Y
Cell Cycle; 2012 Jun; 11(12):2327-36. PubMed ID: 22684299
[TBL] [Abstract][Full Text] [Related]
6. The tumour suppressor CYLD regulates the p53 DNA damage response.
Fernández-Majada V; Welz PS; Ermolaeva MA; Schell M; Adam A; Dietlein F; Komander D; Büttner R; Thomas RK; Schumacher B; Pasparakis M
Nat Commun; 2016 Aug; 7():12508. PubMed ID: 27561390
[TBL] [Abstract][Full Text] [Related]
7. The K48-K63 Branched Ubiquitin Chain Regulates NF-κB Signaling.
Ohtake F; Saeki Y; Ishido S; Kanno J; Tanaka K
Mol Cell; 2016 Oct; 64(2):251-266. PubMed ID: 27746020
[TBL] [Abstract][Full Text] [Related]
8. Chemically synthesized cinobufagin suppresses nasopharyngeal carcinoma metastasis by inducing ENKUR to stabilize p53 expression.
Hou R; Liu X; Yang H; Deng S; Cheng C; Liu J; Li Y; Zhang Y; Jiang J; Zhu Z; Su Y; Wu L; Xie Y; Li X; Li W; Liu Z; Fang W
Cancer Lett; 2022 Apr; 531():57-70. PubMed ID: 35114328
[TBL] [Abstract][Full Text] [Related]
9. [Research progress of deubiquitinating enzyme CYLD to regulate liver-related diseases].
Yang X; An DJ; Gao CC; Qin HY
Zhonghua Gan Zang Bing Za Zhi; 2019 Jun; 27(6):477-480. PubMed ID: 31357769
[TBL] [Abstract][Full Text] [Related]
10. circRNA_0067717 promotes paclitaxel resistance in nasopharyngeal carcinoma by acting as a scaffold for TRIM41 and p53.
Cheng Y; Zhu Y; Xiao M; Zhang Y; Wang Z; Chen H; Cao K
Cell Oncol (Dordr); 2023 Jun; 46(3):677-695. PubMed ID: 36705889
[TBL] [Abstract][Full Text] [Related]
11. CYLD: a tumor suppressor deubiquitinase regulating NF-kappaB activation and diverse biological processes.
Sun SC
Cell Death Differ; 2010 Jan; 17(1):25-34. PubMed ID: 19373246
[TBL] [Abstract][Full Text] [Related]
12. CYLD induces high oxidative stress and DNA damage through class I HDACs to promote radiosensitivity in nasopharyngeal carcinoma.
Li Y; Yang C; Xie L; Shi F; Tang M; Luo X; Liu N; Hu X; Zhu Y; Bode AM; Gao Q; Zhou J; Fan J; Li X; Cao Y
Cell Death Dis; 2024 Jan; 15(1):95. PubMed ID: 38287022
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-372 enhances radiosensitivity while inhibiting cell invasion and metastasis in nasopharyngeal carcinoma through activating the PBK-dependent p53 signaling pathway.
Wang Z; Mao JW; Liu GY; Wang FG; Ju ZS; Zhou D; Wang RY
Cancer Med; 2019 Feb; 8(2):712-728. PubMed ID: 30656832
[TBL] [Abstract][Full Text] [Related]
14. Amyloid aggregates induced by the p53-R280T mutation lead to loss of p53 function in nasopharyngeal carcinoma.
Li J; Guo M; Chen L; Chen Z; Fu Y; Chen Y
Cell Death Dis; 2024 Jan; 15(1):35. PubMed ID: 38212344
[TBL] [Abstract][Full Text] [Related]
15. Immune dysregulation in SHARPIN-deficient mice is dependent on CYLD-mediated cell death.
Ang RL; Chan M; Legarda D; Sundberg JP; Sun SC; Gillespie VL; Chun N; Heeger PS; Xiong H; Lira SA; Ting AT
Proc Natl Acad Sci U S A; 2021 Dec; 118(50):. PubMed ID: 34887354
[TBL] [Abstract][Full Text] [Related]
16. Catalytic domain mutation in CYLD inactivates its enzyme function by structural perturbation and induces cell migration and proliferation.
Johari T; Maiti TK
Biochim Biophys Acta Gen Subj; 2018 Sep; 1862(9):2081-2089. PubMed ID: 29807073
[TBL] [Abstract][Full Text] [Related]
17. Cylindromatosis Lysine 63 Deubiquitinase (CYLD) Regulates NF-kB Signaling Pathway and Modulates Fibroblast and Endothelial Cells Recruitment in Nasopharyngeal Carcinoma.
Deng M; Dai W; Yu VZ; Tao L; Lung ML
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32708712
[TBL] [Abstract][Full Text] [Related]
18. CYLD suppression enhances the pro-inflammatory effects and hyperproliferation of rheumatoid arthritis fibroblast-like synoviocytes by enhancing NF-κB activation.
Zhang LM; Zhou JJ; Luo CL
Arthritis Res Ther; 2018 Oct; 20(1):219. PubMed ID: 30285829
[TBL] [Abstract][Full Text] [Related]
19. FBP1 enhances the radiosensitivity by suppressing glycolysis via the FBXW7/mTOR axis in nasopharyngeal carcinoma cells.
Zhang P; Shao Y; Quan F; Liu L; Yang J
Life Sci; 2021 Oct; 283():119840. PubMed ID: 34298040
[TBL] [Abstract][Full Text] [Related]
20. CYLD Promotes Apoptosis of Nasopharyngeal Carcinoma Cells by Regulating NDRG1.
Lin Y; Wang L; Luo W; Zhou X; Chen Y; Yang K; Liao J; Wu D; Cai L
Cancer Manag Res; 2020; 12():10639-10649. PubMed ID: 33149672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
